Cancer-Risk Analysis Program Goes Public

April 27, 1999

DALLAS - April 27, 1999 - A UT Southwestern Medical Center at Dallas physician-scientist is offering his interactive, comprehensive computer program for breast-cancer risk assessment at no charge to health professionals providing breast care.

Dr. David Euhus, assistant professor of surgical oncology, designed the user-friendly personal computer-based program called "CancerGene," which will collect a family history, draw a pedigree and display probabilities of developing breast cancer at various ages as well as probabilities of inheriting an abnormal breast-cancer-susceptibility gene. Euhus co-directs the Mary L. Brown Breast Cancer Genetics and Risk Assessment Program in the Southwestern Center for Breast Care and is the George and Carol Poston Professor in Breast Cancer Research.

Asked why there is no charge for the computer program, he said, "We're giving it away because it is useful for assisting women who are concerned about their breast-cancer risk. Does there need to be a better reason?"

The program leads breast-care providers through a structured on-screen interview that collects a detailed family history and then displays probabilities in graphs and tables. The outputs include: age-specific probability of developing breast cancer, age-specific probability of developing ovarian cancer and probability of having a BRCA1 or BRCA2 gene mutation. The program employs several models, including Duke University Institute of Statistics and Decisions Sciences' BRCAPRO.

The user also is able to see if the program can suggest another cancer syndrome applicable to the family history by simply clicking on the appropriate button. In addition, "CancerGene" has an easily accessible glossary of cancer syndromes.
-end-
For information about acquiring the "CancerGene" program, visit the Internet site http://www.isds.duke.edu/~gp/brcapro.html.



UT Southwestern Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.